NiKem Research and Chiesi Farmaceutici Extend Research Collaboration
Chiesi Farmaceutici and NiKem Research have announced today details of their extended research collaboration within the…
Chiesi Farmaceutici and NiKem Research have announced today details of their extended research collaboration within the…
The IMS Institute for Healthcare Informatics today reported that global spending for medicines will reach nearly $1.1 tr…
Once-a-day tablet Daxas® (roflumilast) is a first-in-class treatment under development targeting inflammation, the under…
. - New drug application filed for United States - Treatment aimed at patients with symptomatic Chronic Obstructive Pu…
. - Adjusted EBITDA increased 1.0% to €307.0m (Q1/08: €304.0m) - Total net turnover increased 1.2% to €839.9m (Q1/08:…
. - Markets responding differently to negative economic conditions - U.S. market to decline in 2009 - Pharmerging m…
In the first six months of 2008, Nycomed's adjusted EBITDA increased by 4.9% to € 653.7 million compared to € 623.3 mill…